Adenosine reverses life-threatening persistent pulmonary hypertension of the neonate refractory to triple vasodilator therapy.
| Autor: | Genet L; Division of Pediatrics and Neonatal Critical Care, 'A.Béclère' Medical Center, Paris Saclay University Hospitals, APHP, Paris, France., De Luca D; Division of Pediatrics and Neonatal Critical Care, 'A.Béclère' Medical Center, Paris Saclay University Hospitals, APHP, Paris, France.; Physiopathology and Therapeutic Innovation Unit-INSERM U999, Paris Saclay University, Paris, France. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Cardiology in the young [Cardiol Young] 2022 Jun; Vol. 32 (6), pp. 996-997. Date of Electronic Publication: 2021 Oct 13. |
| DOI: | 10.1017/S1047951121004157 |
| Abstrakt: | Persistent pulmonary hypertension of the neonate can cause acute and life-threatening hypoxia, but preterm neonates are not suitable candidate to extra-corporeal life support. We report the unique case of an extremely preterm neonates with life-threatening persistent pulmonary hypertension refractory to triple vasodilator therapy (nitric oxide, iloprost, and bosentan), which has been successfully treated with the addition of adenosine continuous infusion. |
| Databáze: | MEDLINE |
| Externí odkaz: |
|